miR-429 mediates δ-tocotrienol-induced apoptosis in triple-negative breast cancer cells by targeting XIAP; miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting Bcl-2 and XIAP. Here, BCL2 is linked to triple-negative breast carcinoma.